RNF123 (Ring Finger Protein 123) is an E3 ubiquitin-protein ligase involved in the ubiquitin-proteasome pathway, responsible for tagging specific proteins for degradation. When considering indirect strategies, one might focus on molecules that interfere with the ubiquitin-proteasome system or E3 ligase functions in general. RNF123 inhibitors belong to a class of molecules designed to modulate the activity of the Ring Finger Protein 123, abbreviated as RNF123. This protein is an E3 ubiquitin-protein ligase, a component of the ubiquitin-proteasome system responsible for attaching ubiquitin molecules to specific protein substrates. This ubiquitination often marks proteins for degradation, influencing protein turnover and homeostasis within cells. Given its pivotal role, any disruption or modulation of RNF123's ligase function can significantly influence various cellular processes, ranging from protein stability, signal transduction, to cell cycle progression.
The mechanism of action of RNF123 inhibitors can vary. Some might interfere directly with the protein's active or binding sites, it from attaching ubiquitin to its substrates. Others might target the protein's interaction with E2 ubiquitin-conjugating enzymes, which are essential collaborators in the ubiquitination process. Additionally, certain inhibitors the activation or recruitment of RNF123 to specific cellular locations or complexes, thereby reducing its functional activity. Molecular specificity is crucial, as off-target effects could lead to the unintended modulation of other ubiquitin ligases or related cellular pathways. Given the complexity of the ubiquitin-proteasome system and the myriad of proteins involved, achieving this specificity can be challenging.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that prevents the degradation of ubiquitinated proteins. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Another proteasome inhibitor, primarily studied in the research of multiple myeloma. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $286.00 | 1 | |
An inhibitor of NEDD8-activating enzyme (NAE). By inhibiting NAE, MLN4924 disrupts the neddylation process, which is essential for the activation of cullin-RING ligases, a subclass of E3 ubiquitin ligases. | ||||||